CIP2A inhibitors constitute a diverse chemical class of compounds recognized for their distinctive capability to target and interact with the Cancerous Inhibitor of PP2A (CIP2A) protein, a molecule that plays a crucial role in cellular signaling pathways associated with oncogenesis. The unique structural attributes of CIP2A inhibitors enable them to disrupt the interaction between CIP2A and its substrate, Protein Phosphatase 2A (PP2A), which is an essential enzyme with tumor-suppressive functions. These inhibitors typically possess a range of chemical scaffolds that are optimized to effectively bind to specific regions of the CIP2A protein, obstructing its ability to hinder PP2A's tumor-suppressive activities.
The chemical diversity within the CIP2A inhibitor class is characterized by variations in molecular weight, stereochemistry, and functional groups. Many inhibitors feature aromatic moieties, heterocyclic rings, and hydrophobic side chains that facilitate strong interactions with the hydrophobic regions of CIP2A, thus enhancing their binding affinity. Structural modifications and derivatization of these compounds have been explored to optimize their potency and selectivity for CIP2A inhibition. Some CIP2A inhibitors leverage hydrogen bonding, electrostatic interactions, and π-π stacking interactions to establish stable complexes with the target protein. The chemical class of CIP2A inhibitors continues to be a subject of active research, as scientists strive to uncover novel compounds with improved binding affinities and pharmacokinetic properties.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Some studies have suggested that retinoic acid, a derivative of Vitamin A, can suppress CIP2A expression and consequently inhibit its tumor-promoting effects. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $33.00 $77.00 $120.00 | 14 | |
FTY720 is a sphingosine analog that has been investigated for its potential to inhibit CIP2A and promote PP2A activity in certain cancer cells. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $158.00 | 6 | |
Celastrol is a natural compound that has shown potential as a CIP2A inhibitor in research studies. | ||||||
Sanguinarium | 2447-54-3 | sc-473396 | 10 mg | $220.00 | ||
Sanguinarium has been investigated for its anti-cancer properties, including its ability to inhibit CIP2A. | ||||||
Arctigenin | 7770-78-7 | sc-202957 | 25 mg | $83.00 | 14 | |
Arctigenin is a natural lignan compound found in plants, and it has been studied for its potential to inhibit CIP2A and suppress cancer cell growth. | ||||||
Nilotinib | 641571-10-0 | sc-202245 sc-202245A | 10 mg 25 mg | $209.00 $413.00 | 9 | |
While primarily known as a tyrosine kinase inhibitor, nilotinib has also been studied for its potential to inhibit CIP2A in cancer cells | ||||||